Presenting author

Jason Harris

1 presentation

• W115. Elunetirom, a first-in-class, brain-targeting, antidepressant candidate in Ph2 development, triggers robust bioenergetic and neuroplastic improvements in preclinical studies

  2026 ASCP Annual Meeting